Garden Stage (GSIW) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
20 Jan, 2026Executive summary
Revenues for the six months ended September 30, 2025, surged 382.9% year-over-year to $3.4 million, driven by growth across most service lines.
Net loss widened by 98.3% to $6.5 million, primarily due to significant increases in professional fees and technology investments.
Financial highlights
Advisory fees reached $215,918, up from nil, reflecting new advisory engagements.
Brokerage commissions rose 274.6% to $611,965, with strong demand in both U.S. and Hong Kong markets.
Introducing and referral income soared 393.1% to $1.63 million, mainly from a key customer.
Underwriting and placement income jumped 519.9% to $509,848, driven by a new bond placement.
Total expenses increased 148.2% to $9.89 million, with professional fees up 875.1% to $3.1 million due to acquisition-related costs and share-based compensation.
Net cash used in operating activities was $3.41 million, while $14.57 million was raised from share issuance.
Outlook and guidance
A private placement offering to raise approximately $6 million is expected to close by January 2026.
Latest events from Garden Stage
- Hong Kong-based financial group targets $100M shelf offering amid regulatory and market risks.GSIW
Registration Filing16 Dec 2025 - Hong Kong-based financial services firm seeks to raise up to $100M amid regulatory and market risks.GSIW
Registration Filing16 Dec 2025 - Form F-3 enables ongoing U.S. offerings, led by Sze Ho Chan, with robust governance.GSIW
Registration Filing16 Dec 2025 - FY2024 revenue dropped 56.8% and net loss widened to $4.6M amid lower deal flow and higher costs.GSIW
H2 202412 Dec 2025 - Resale of 1,750,000 shares by the controlling shareholder, no proceeds to the company.GSIW
Registration Filing29 Nov 2025 - Resale of 1,750,000 shares by a controlling shareholder amid regulatory and financial headwinds.GSIW
Registration Filing29 Nov 2025